Skip to main content
Premium Trial:

Request an Annual Quote

Distribution Deals Drive Growth in WaferGen's Q2 Revenues, Net Loss Doubles

NEW YORK (GenomeWeb News) - WaferGen today reported revenues of $177,000 for the quarter ended June 30, 2008, compared to $300 for the second quarter of 2007.
The company said that the revenue increase was due to several international distributorships for its SmartSlide micro-incubation system that it signed recently in Germany as well as other European and Asian regions, in addition to the expansion of its internal sales team.
WaferGen’s second-quarter R&D expenses more than tripled, meantime, to $1.3 million from $362,000 in the prior-year period. This increase resulted primarily “from an increase in headcount, an increase in research and development materials and supplies used for product development and testing, the company's move to a new facility and associated expenses, and an increase in stock-based compensation associated with the issuance of stock options,” WaferGen said.
Sales and marketing expenses also rose, to $296,000 from $138,000 in the second quarter of 2007, while general and administrative expenses increased to $634,000 from $384,000 in the year-ago quarter.
WaferGen’s second-quarter net loss more than doubled, to $2.1 million, or $.09 per share, from $1 million, or $.10 per share, for the quarter ended June 30, 2007.
As of June 30, WaferGen had $4.3 million in cash and cash equivalents.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.